Clinical trial · Observational
The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project will target patients with histopathologically diagnosed mucosal melanoma using \[¹⁸F\]FDG PET/CT imaging for retrospective prognostic evaluation.The primary objective is to explore the value of \[¹⁸F\]FDG PET/CT imaging in the prognostic assessment of mucosal melanoma, and to determine the correlations between quantitative \[¹⁸F\]FDG PET parameters and progression-free survival (PFS) as well as overall survival (OS), so as to provide reference evidence for individualized treatment decision-making.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| FDG PET | — | UNRESOLVED | — |
| Mucosal Melanoma | Mucosal Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Telephone follow-up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Mucosal Melanoma Cohort
- description
- Retrospective cohort of mucosal melanoma patients who underwent \[18F\]FDG PET/CT for prognostic evaluation.
- interventionNames
- Other: Telephone follow-up
Primary outcomes (2)
- measure
- Overall survival
- timeFrame
- Up to 4 years
- description
- Overall survival (OS) is defined as the time elapsed from the date of the ¹⁸F-FDG PET/CT examination to the date of death.
- measure
- Progression-free survival
- timeFrame
- Up to 4 years
- description
- Progression-free survival (PFS) is defined as the time from the date of \[18F\]FDG PET/CT imaging to the earliest date of disease progression, recurrence, or death.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with histopathologically confirmed mucosal melanoma. Exclusion Criteria: 1. Having another primary malignancy (other than mucosal melanoma). 2. Being lost to follow-up. 3. Being under 18 years of age. 4. Being pregnant or breastfeeding.
References
Publications (0)
Data not yet available